Industry Verticals »

All Categories

Insights »

About TMR »

Absorbable Antibacterial Envelope Market

Absorbable Antibacterial Envelope Market (Application: Implantable Cardioverter Defibrillators [ICDs], Cardiac Resynchronization Therapy Defibrillators [CRT-D), and Cardiac Resynchronization Therapy Pacemakers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Absorbable Antibacterial Envelope Market Outlook 2031

  • The global industry was valued at US$ 32.5 Mn in 2021
  • It is projected to grow at a CAGR of 5.8% from 2022 to 2031 and reach US$ 56.9 Mn by the end of 2031

Analysts’ Viewpoint

High morbidity and mortality rate of heart failure, despite breakthroughs in treatment, is driving the global absorbable antibacterial envelope market. Mortality in heart failure patients is not always related to hemodynamic failure, but can also be due to ventricular arrhythmias. Usage of implantable cardioverter defibrillators (ICDs) to reduce arrhythmic sudden deaths is expected to augment the market in the next few years. Furthermore, cardiac resynchronization therapy (CRT) is another promising treatment option for people with heart failure.

Increase in geriatric population; rise in number of people adopting sedentary lifestyles; high tobacco and alcohol consumption; and adoption of unbalanced diet are anticipated to augment the absorbable antibacterial envelope market. Manufacturers are focusing on developing effective and low-cost products for the treatment of heart failure to increase their market share.

Absorbable Antibacterial Envelope Market

Market Introduction

Absorbable antibacterial envelope is a single-use device that holds a cardiac implantable electronic device or implanted neurostimulator. It is designed to stabilize the device after implantation, while releasing antibacterial agents. It can be made from multifilament, knitted absorbable mesh, or extracellular matrix (ECM) derived from porcine small intestinal submucosa. The envelope is fully absorbed by the body within few weeks after implantation.

Cardiovascular implantable electronic devices, such as implantable cardioverter defibrillator (ICDs), cardiac resynchronization therapy defibrillator (CRT-D), and cardiac resynchronization therapy pacemaker (CRT-P), are used to treat arrhythmias or abnormal heart rhythms. These devices are surgically implanted inside the body to ensure that the heart beats at a consistent rate that matches the needs of the individual.

High prevalence of cardiovascular diseases across the globe and constant research & development activities in product advancements are likely to drive industry growth during the forecast period.

Rise in Prevalence of Cardiovascular Diseases to Bolster Absorbable Antibacterial Envelope Market

Cardiovascular diseases (CVDs) are a leading cause of death across the world. According to the World Health Organization (WHO), CVDs account for nearly 17.9 million deaths every year, which is estimated to be 31% of all global deaths. According to CDC, 18.2 million adults aged 20 and older (about 6.7%) have coronary artery disease (CAD) in the U.S. Out of 10, two deaths occur from CAD in adults less than 65 years old.

Rise in prevalence of cardiovascular diseases in developing countries can be linked to the increase in incidence of hypertension, smoking, and obesity led by changing lifestyles and a surge in incidence of diabetes and pre-diabetes. Thus, rise in prevalence of cardiovascular diseases is driving the need for cardiovascular monitoring devices. Therefore, presence of a large patient pool with cardiovascular diseases is projected to fuel market expansion during the forecast period.

Rise in Geriatric Population to Augment Global Market Statistics

According to a study published in the American Journal of Medicine, the U.S. population is aging rapidly. Increase in life expectancy is expected to result in doubling of the population aged 65 years or above (from 40 million people in 2010 to 81 million by 2040).

Aging is one of the key factors responsible for the increase in incidence of chronic diseases such as hypertension and high blood cholesterol level. This is likely to drive the demand for cardiac procedures for heart failure.

Mortality rate is the highest in Eastern Europe and middle-income countries. Overall CVD death rates are higher in low- and middle-income countries than those in developed nations. Thus, increase in population aged 65 years or above is augmenting the demand for cardiac implantable electronic devices (CIEDs) including pacemakers and defibrillators. This is anticipated to bolster market development during the forecast period.

Prevention of Sudden Cardiac Arrest Fueling Cardiac Resynchronization Therapy Defibrillators Segment

In terms of application, the cardiac resynchronization therapy-defibrillator (CRT-D) segment dominated the global absorbable antibacterial envelope market, with around 40% share in 2021. CRT-D is a specialist device used to treat individuals who have heart failure or are at the risk of sudden cardiac death. Overly rapid heart rhythms (more than 100 beats per minute) can cause a sudden cardiac arrest, which the device can also address. The CRT-D device delivers an electric shock to the heart (defibrillation) If it detects abnormally fast heartbeats. This shock stops any aberrant cardiac rhythms.

High Usage of Absorbable Antibacterial Envelope Bolstering Hospitals Segment

Based on end-user, the hospitals segment is projected to account for a dominant share of the global absorbable antibacterial envelope market from 2022 to 2031. Large share of the hospitals segment can be ascribed to the increase in usage of absorbable antibacterial envelope in cardiac implantable devices across hospitals.

The ambulatory surgical centers segment is anticipated to expand at a high CAGR from 2022 to 2031. Surge in preference for ambulatory surgical centers — these are high quality, cost-effective settings for cardiac patients and cardiovascular procedures — is expected to propel the segment during the forecast period.

Regional Outlook for Absorbable Antibacterial Envelope Market

North America accounted for the largest share of more than 40% in 2021. The industry in the region is projected to expand at a CAGR of 5.5% from 2022 to 2031. This can be ascribed to the higher rate of adoption of absorbable antibacterial envelope in developed regions, including North America, as only commercial available antibacterial envelope products by Medtronic plc and Aziyo Biologics, Inc. have reported high sales.

Asia Pacific was the fastest growing region in 2021. The business in the region is expected to expand at a CAGR of 6.4% during the forecast period. This can be ascribed to large population in countries such as India and China, significant geriatric population in Japan, and improving health care facilities. Additionally, rise in awareness about cardiovascular diseases and untapped opportunities are expected to augment market progress in the region during the forecast period.

Analysis of Key Players

The global absorbable antibacterial envelope market is highly consolidated, with the presence of only two key players. Advancements in available products and mergers & acquisitions are the key strategies adopted by the players. The industry is consolidated, with the presence of small number of players. Key players in the market are Medtronic plc and Aziyo Biologics, Inc.

Key Developments in Global Absorbable Antibacterial Envelope Market

  • In April 2022, Aziyo Biologics, Inc. announced that it had filed a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for CanGaroo RM Antibacterial Envelope, its next-generation biomaterial envelope for use with implantable electronic devices (IED). The company intends to bring to the U.S. a version of its existing FDA-approved CanGaroo envelope enhanced with the antibiotics Rifampin and Minocycline in dissolvable polymer rings. Addition of antibiotics to the biomaterial envelope is designed to reduce the risk of bacterial colonization.
  • In February 2021, India Medtronic Private Limited announced the launch of the TYRX Absorbable Antibacterial Envelope (TYRX Envelope), an absorbable, single-use, antibacterial envelope that stabilizes a cardiac implantable electronic device (CIED) or implanted neurostimulator and at the same time releases antimicrobial agents for seven days.
  • In January 2021, Aziyo Biologics, Inc. received CE Mark approval for updated labeling of the CanGaroo Envelope to allow for the addition of the antibiotic gentamicin. The indications of CanGaroo Envelope remain unchanged. However, this approval now permits the envelope to be hydrated in a gentamicin solution during device preparation prior to implantation. Pre-clinical testing has demonstrated that hydrating the CanGaroo Envelope in gentamicin prior to use can reduce or inhibit bacterial growth.
  • In September 2020, Medtronic plc announced new data from the landmark WRAP-IT study. The data indicates that the TYRX Absorbable Antibacterial Envelope (TYRX Envelope) is cost-effective for patients at increased risk of infections who receive cardiac implantable electronic devices (CIEDs). The analysis demonstrates the envelope's cost-effectiveness compared to standard-of-care infection prevention strategies in the U.S. healthcare system.

Each of these players has been profiled in the absorbable antibacterial envelope market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Absorbable Antibacterial Envelope Market Snapshot

Attribute

Detail

Size in 2021

US$ 32.5 Mn

Forecast (Value) in 2031

US$ 56.9 Mn

Growth Rate

5.8%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

Market share analysis by company (2021)

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials.

Format

Electronic (PDF) + Excel

Segmentation
  • Application
    • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
    • Implantable Cardioverter Defibrillators (ICD)
    • Cardiac Resynchronization Therapy Pacemakers (CRT-P)
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Others

Regions Covered
  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Companies Profiled
  • Medtronic plc
  • Aziyo Biologics, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global absorbable antibacterial envelope market in 2021?

It was valued at US$ 32.5 Mn in 2021.

How big will the industry be in 2031?

It is projected to reach US$ 56.9 Mn by 2031.

What was the CAGR from 2017 to 2021?

The CAGR was 2.4% from 2017 to 2021.

What will be the CAGR during the forecast period?

The CAGR is expected to be 5.8% from 2022 to 2031.

What are the prominent trends affecting market growth?

Increase in patient population with cardiovascular diseases, surge in the geriatric population, and changing lifestyle leading to cardiovascular diseases.

What was the share of the leading segment in 2021?

The resting ECG systems segment held more than 40% share in 2021.

Which region will account for major share during the forecast period?

North America is projected to account for major share from 2022 to 2031.

Who are the prominent players in the global market?

Medtronic plc and Aziyo Biologics, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Absorbable Antibacterial Envelope Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Technological Advancements

        5.2. Regulatory Scenario by Region/globally

        5.3. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, by Application

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Application, 2017–2031

            6.3.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)

            6.3.2. Implantable Cardioverter Defibrillators (ICD)

            6.3.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)

        6.4. Market Attractiveness Analysis, by Application

    7. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals

            7.3.2. Ambulatory Surgical Centers

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Absorbable Antibacterial Envelope Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Application, 2017–2031

            9.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)

            9.2.2. Implantable Cardioverter Defibrillators (ICD)

            9.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Ambulatory Surgical Centers

            9.3.3. Others

        9.4. Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Application

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Absorbable Antibacterial Envelope Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Application, 2017–2031

            10.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)

            10.2.2. Implantable Cardioverter Defibrillators (ICD)

            10.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals

            10.3.2. Ambulatory Surgical Centers

            10.3.3. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Application

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Absorbable Antibacterial Envelope Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Application, 2017–2031

            11.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)

            11.2.2. Implantable Cardioverter Defibrillators (ICD)

            11.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)

        11.3. Market Value Forecast, by End-user, 2017–2031

            11.3.1. Hospitals

            11.3.2. Ambulatory Surgical Centers

            11.3.3. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. India

            11.4.3. Japan

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Application

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Absorbable Antibacterial Envelope Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Application, 2017–2031

            12.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)

            12.2.2. Implantable Cardioverter Defibrillators (ICD)

            12.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)

        12.3. Market Value Forecast, by End-user, 2017–2031

            12.3.1. Hospitals

            12.3.2. Ambulatory Surgical Centers

            12.3.3. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Application

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Absorbable Antibacterial Envelope Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Application, 2017–2031

            13.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)

            13.2.2. Implantable Cardioverter Defibrillators (ICD)

            13.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)

        13.3. Market Value Forecast, by End-user, 2017–2031

            13.3.1. Hospitals

            13.3.2. Ambulatory Surgical Centers

            13.3.3. Others

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Application

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company, 2021

        14.3. Company Profiles

            14.3.1. Medtronic plc

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Aziyo Biologics, Inc.

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

    List of Tables

    Table 1: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 2: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 3: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 4: North America Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 5: North America Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 6: North America Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 7: Europe Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 8: Europe Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 9: Europe Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Asia Pacific Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: Asia Pacific Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: Asia Pacific Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Latin America Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 14: Latin America Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 15: Latin America Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Middle East & Africa Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Middle East & Africa Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 18: Middle East & Africa Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 1: Global Absorbable Antibacterial Envelope Market Value (US$ Mn), 2017–2031

    Figure 2: Global Absorbable Antibacterial Envelope Market Value Share, by Application, 2021

    Figure 3: Global Absorbable Antibacterial Envelope Market Value Share, by End-user, 2021

    Figure 4: Global Absorbable Antibacterial Envelope Market Value Share, by Region, 2021

    Figure 5: Global Absorbable Antibacterial Envelope Market Value Share Analysis, by Application, 2021 and 2031

    Figure 6: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiac Resynchronization Therapy Defibrillators (CRT-D), 2017–2031

    Figure 7: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Implantable Cardioverter Defibrillators (ICD), 2017–2031

    Figure 8: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiac Resynchronization Therapy Pacemakers (CRT-P), 2017–2031

    Figure 9: Global Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Application, 2022-2031

    Figure 10: Global Absorbable Antibacterial Envelope Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 11: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2017–2031

    Figure 12: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2031

    Figure 13: Global Absorbable Antibacterial Envelope Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2017–2031

    Figure 14: Global Absorbable Antibacterial Envelope Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 15: Global Absorbable Antibacterial Envelope Market Value Share Analysis, by Region, 2021 and 2031

    Figure 16: Global Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Region, 2022-2031

    Figure 17: North America Absorbable Antibacterial Envelope Market (US$ Mn) Forecast, 2017–2031

    Figure 18: North America Absorbable Antibacterial Envelope Market Value Share Analysis, by Application, 2021 and 2031

    Figure 19: North America Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Application, 2022-2031

    Figure 20: North America Absorbable Antibacterial Envelope Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 21: North America Absorbable Antibacterial Envelope Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 22: North America Absorbable Antibacterial Envelope Market Value Share Analysis, by Country, 2021 and 2031

    Figure 23: North America Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Country 2022-2031

    Figure 24: Europe Absorbable Antibacterial Envelope Market (US$ Mn) Forecast, 2017–2031

    Figure 25: Europe Absorbable Antibacterial Envelope Market Value Share Analysis, by Application, 2021 and 2031

    Figure 26: Europe Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Application, 2022-2031

    Figure 27: Europe Absorbable Antibacterial Envelope Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 28: Europe Absorbable Antibacterial Envelope Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 29: Europe Absorbable Antibacterial Envelope Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

    Figure 30: Europe Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

    Figure 31: Asia Pacific Absorbable Antibacterial Envelope Market (US$ Mn) Forecast, 2017–2031

    Figure 32: Asia Pacific Absorbable Antibacterial Envelope Market Value Share Analysis, by Application, 2021 and 2031

    Figure 33: Asia Pacific Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Application, 2022-2031

    Figure 34: Asia Pacific Absorbable Antibacterial Envelope Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 35: Asia Pacific Absorbable Antibacterial Envelope Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 36: Asia Pacific Absorbable Antibacterial Envelope Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 37: Asia Pacific Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

    Figure 38: Latin America Absorbable Antibacterial Envelope Market (US$ Mn) Forecast, 2017–2031

    Figure 39: Latin America Absorbable Antibacterial Envelope Market Value Share Analysis, by Application, 2021 and 2031

    Figure 40: Latin America Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Application, 2022-2031

    Figure 41: Latin America Absorbable Antibacterial Envelope Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 42: Latin America Absorbable Antibacterial Envelope Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 43: Latin America Absorbable Antibacterial Envelope Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 44: Latin America Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

    Figure 45: Middle East & Africa Absorbable Antibacterial Envelope Market (US$ Mn) Forecast, 2017–2031

    Figure 46: Middle East & Africa Absorbable Antibacterial Envelope Market Value Share Analysis, by Application, 2021 and 2031

    Figure 47: Middle East & Africa Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Application, 2022-2031

    Figure 48: Middle East & Africa Absorbable Antibacterial Envelope Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 49: Middle East & Africa Absorbable Antibacterial Envelope Market Attractiveness Analysis, by End-user, 2022-2031

    Figure 50: Middle East & Africa Absorbable Antibacterial Envelope Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 51: Middle East & Africa Absorbable Antibacterial Envelope Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

    Figure 52: Global Absorbable Antibacterial Envelope Market Share Analysis, by Company (2021)

Copyright © Transparency Market Research, Inc. All Rights reserved

Absorbable Antibacterial Envelope Market

Schedule a Call